![]() | Elliot S GershonDepartment of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA | Department of Psychiatry, Department of Human Genetics, University of Chicago, ... |
KOL Resume for Elliot S Gershon
Year | |
---|---|
2022 | Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA University of Chicago, Chicago, IL, United States of America. |
2021 | Department of Psychiatry, University of Chicago, Chicago, Illinois, USA University of Chicago, United States |
2020 | University of Chicago, Department of Psychiatry and Behavioral Neurosciences; |
2019 | Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States. Electronic address: University of Chicago, 5841 S. Maryland Ave, Chicago, IL, 60637, USA. |
2018 | Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago, IL, USA |
2017 | Department of Psychiatry, Department of Human Genetics, University of Chicago, United States University of Chicago; |
2016 | Department of Psychiatry, University of Chicago, Chicago, IL USA |
2015 | Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, Illinois |
2014 | Department of Psychiatry and Behavioral Neuroscience; Department of Human Genetics; University of Chicago, Illinois, USA. |
2013 | From the Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago. Department of Psychiatry, Institute of Human Genetics, The University of Illinois at Chicago, Chicago, IL 60607 (LC, CZ and CL), the Laboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Saitama 351-0198, and Sangenjaya Station Mental Health Clinic, Tokyo 154-0024, Japan (EH), the Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, 466-8560 Japan (AN), the Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL 60637 (NAS, MDO, KG, SCD, ESG), and the Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA 70112 (YPT) |
2012 | Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, US 60637 |
2011 | Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois, United States of America |
2010 | Department of Human Genetics, The University of Chicago, Chicago, IL 60637, USA |
2009 | Departments of Psychiatry and Human Genetics, the University of Chicago, Chicago, Illinois, United States of America Department of Human Genetics, University of Chicago, Chicago, Illinois |
2008 | Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA |
2007 | Department of Psychiatry, The University of Chicago, Chicago, Illinois |
2006 | University of Chicago, Chicago, Illinois |
2005 | US Department of Health and Human Services, NIMH Genetics Initiative Bipolar Consortium, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA |
2004 | Laboratory of Clinical Science (DLM), National Institute of Mental Health, Bethesda;, USA |
2003 | Department of Psychiatry (FJM, ESG, JAB), University of Chicago, Chicago, Illinois, USA |
2002 | Department of Psychiatry, The University of Chicago, Chicago, Illinois, 60637, USA |
2001 | Department of Psychiatry, University of Chicago, Chicago, III, USA. |
2000 | Clinical Neurogenetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland Dept of Psychiatry, University of Chicago, Chicago, IL, USA |
1999 | Clinical Neurogenetics Branch, National Institute of Mental Health, and Genetic Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Department of Psychiatry, University of Chicago, Chicago, IL 60637; Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104; and Medical and Molecular Genetics and Psychiatry, Indiana University, Indianapolis, IN 46202 National Institute of Mental Health, Bethesda, Maryland University of Chicago, Illinois |
1998 | Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda |
1997 | Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda, Maryland, 20892 National Institutes of Mental Health, Bethesda, Maryland |
Elliot S Gershon: Influence Statistics
Concept | World rank |
---|---|
22 bipolar | #1 |
interview diagnosis relatives | #1 |
rare common cnvs | #1 |
genomewide scale data | #1 |
lifetime psychiatric diagnosis | #1 |
affective disorders unipolar | #1 |
d13s779d13s225 | #1 |
hla bipolar | #1 |
d13s71 d13s274 | #1 |
g72 messenger reflex | #1 |
model iii mendlewicz | #1 |
potential loci | #1 |
dominant recessive models | #1 |
long putative isoform | #1 |
380 relatives | #1 |
schizophrenia oligogenic diseases | #1 |
locus dbh | #1 |
greatest allele sharing | #1 |
m18 m22 | #1 |
common cnvs birdsuite | #1 |
affective disorders relatives | #1 |
sib pair methods | #1 |
tci zkpq | #1 |
0 recombination | #1 |
common ascertainment | #1 |
13q32 | #1 |
scz g72 g30 | #1 |
reproducibility psychiatric diagnosis | #1 |
neuron protection function | #1 |
subscales zkpq | #1 |
risk counseling process | #1 |
transmitted factors | #1 |
asians scz | #1 |
acceptable fit gershon | #1 |
cacna1c patient | #1 |
genetic linkage association | #1 |
schizoaffective bipolar | #1 |
pharmacogenetic case report | #1 |
transmission bias snps | #1 |
25 pairs sibs | #1 |
diagnoses biological relatives | #1 |
observable morbid risk | #1 |
phenotypewide significance | #1 |
75 bipolar | #1 |
partek software suites | #1 |
chromosome coding regions | #1 |
genetic heterogeneity reports | #1 |
linkage linkage evidence | #1 |
accuracy rare cnvs | #1 |
psychiatric disorders linkage | #1 |
Open the FULL List in Excel | |
Prominent publications by Elliot S Gershon
BACKGROUND: Difficulty recognizing facial emotions is an important social-cognitive deficit associated with psychotic disorders. It also may reflect a familial risk for psychosis in schizophrenia-spectrum disorders and bipolar disorder.
OBJECTIVE: The objectives of this study from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium were to: 1) compare emotion recognition deficits in schizophrenia, schizoaffective disorder and bipolar disorder with psychosis, ...
Known for Bipolar Disorder | Emotion Recognition | Intermediate Phenotypes | Deficits Schizophrenia | Neutral Faces |
OBJECTIVE: Familial neuropsychological deficits are well established in schizophrenia but remain less well characterized in other psychotic disorders. This study from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) consortium 1) compares cognitive impairment in schizophrenia and bipolar disorder with psychosis, 2) tests a continuum model of cognitive dysfunction in psychotic disorders, 3) reports familiality of cognitive impairments across psychotic disorders, and ...
Known for Psychotic Bipolar | Cognitive Impairments | Disorder Schizophrenia | Intermediate Phenotypes | Firstdegree Relatives |
The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample
[ PUBLICATION ]
BACKGROUND: Bipolar disorder is a serious and common psychiatric disorder characterized by manic and depressive mood switches and a relapsing and remitting course. The cornerstone of clinical management is stabilization and prophylaxis using mood-stabilizing medications to reduce both manic and depressive symptoms. Lithium remains the gold standard of treatment with the strongest data for both efficacy and suicide prevention. However, many patients do not respond to this medication, and ...
Known for Lithium Response | Bipolar Disorder | Genome Wide | Valproic Acid | Retrospective Studies |
Measurements of dopamine-beta-hydroxylase (DBH), catechol-O-methyltransferase (COMT), and monoamine oxidase (MAO) along with 27 polymorphic marker phenotypes were available for 162 patients with major affective disorders and 1,125 of their relatives. Levels of enzymes were previously found not to be associated with illness. Pedigree analysis methods for quantitative traits are used to test single-gene hypotheses for segregation of DBH in 32 families with 411 individuals. COMT in 30 ...
Known for Dbh Activity | Abo Locus | Linkage Studies | Monoamine Oxidase | Plasma Dopamine |
Initial Genome Scan of the NIMH Genetics Initiative Bipolar Pedigrees: Chromosomes 4, 7, 9, 18, 19, 20, and 21q
[ PUBLICATION ]
An initial genome scan was performed on 540 individuals from 97 families segregating bipolar disorder, collected through the National Institutes of Mental Health Genetics Initiative. We report here affected-sib-pair (ASP) data on 126 marker loci (approximately 68,000 genotypes) mapping to chromosomes 4, 7, 9, 18, 19, 20, and 21q, under three affection status models. Modest increases in identical-by-descent (IBD) allele sharing were found at the following loci: D4S2397 and D4S391 (P < ...
Known for Chromosomes Human | Mental Health | Genome Scan | Genetics Initiative | Bipolar Disorder |
Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22
[ PUBLICATION ]
As part of the four-center NIMH Genetics Initiative on Bipolar Disorder we carried out a genomic scan of chromosomes 3, 5, 15, 16,17, and 22. Genotyping was performed on a set of 540 DNAs from 97 families, enriched for affected relative pairs and parents where available. We report here the results of the initial 74 markers that have been typed on this set of DNAs. The average distance between markers (theta) was 12.3 cM. Nonparametric analysis of excess allele sharing among affected ...
Known for Chromosomes Human | Nimh Genetics Initiative | Linkage Bipolar Disorder | Region Chromosome | Mental Health |
Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series.
[ PUBLICATION ]
Linkage evidence suggests that chromosome 13 (13q32-33) contains susceptibility genes for both bipolar disorder and schizophrenia. Recently, genes called "G72" and "G30" were identified, and polymorphisms of these overlapping genes were reported to be associated with schizophrenia. We studied two series of pedigrees with bipolar disorder: the Clinical Neurogenetics (CNG) pedigrees (in which linkage to illness had been previously reported at 13q32-33), with 83 samples from 22 multiplex ...
Known for G72 G30 | Gene Locus | Bipolar Disorder Schizophrenia | Pedigree Series | Linkage Evidence |
Comorbid Bipolar Disorder and Panic Disorder in Families With a High Prevalence of Bipolar Disorder
[ PUBLICATION ]
OBJECTIVE: Panic attacks are a common complication of affective disorder, although the etiologic relationship of panic and affective symptoms has not been determined. Evidence from a family study suggests that panic attacks and panic disorder may be related genetically to bipolar disorder. This study used diagnostic data from the NIMH Bipolar Disorder Genetics Initiative to assess in a separate, larger family set the familiality of panic combined with bipolar disorder.
METHOD: ...
Known for Panic Disorder | Degree Relatives | Comorbid Bipolar | Major Affective | Psychiatric Status |
Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm
[ PUBLICATION ]
Several previous studies suggest that dysfunction of circadian rhythms may increase susceptibility to bipolar disorder (BP). We conducted an association study of five circadian genes (CRY2, PER1-3, and TIMELESS) in a family collection of 36 trios and 79 quads (Sample I), and 10 circadian genes (ARNTL, ARNTL2, BHLHB2, BHLHB3, CLOCK, CRY1, CSNK1D, CSNK1E, DBP, and NR1D1) in an extended family collection of 70 trios and 237 quads (Sample II), which includes the same 114 families but not ...
Known for Clock Gene | Bipolar Disorder | Circadian Rhythm | Association Snps | Single Nucleotide |
Initial genome scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 1, 6, 8, 10, and 12
[ PUBLICATION ]
A report on an initial genome screen on 540 individuals in 97 families was collected as part of the NIMH Genetics Initiative on Bipolar Disorder. Families were ascertained to be informative for genetic linkage and underwent a common ascertainment and assessment protocol at four clinical sites. The sample was genotyped for 65 highly polymorphic markers from chromosomes 1, 6, 8, 10, and 12. The average intermarker interval was 16 cM. Genotypic data was analyzed using affected sib pair, ...
Known for Human Pair | Chromosomes 1 | Nimh Genetics Initiative | Initial Genome Scan | Mental Health |
Initial genome screen for bipolar disorder in the NIMH genetics initiative pedigrees: Chromosomes 2, 11, 13, 14, and X
[ PUBLICATION ]
We report on an initial genome screen of 540 individuals from 97 families collected as part of the NIMH Genetics Initiative Bipolar Group. Among the individuals studied, 232 were diagnosed with bipolar (BP) I, 72 with BPII, 88 with major depressive disorder-recurrent type (UPR), and 32 with schizoaffective disorder, bipolar type (SA/BP). A total of 53 markers on chromosomes 2, 11, 13, 14, and X (average spacing: 11.5 cM) were studied at Johns Hopkins University. Tests for linkage were ...
Known for Chromosomes 2 | Bipolar Disorder | Human Pair | Genome Screen | Nimh Genetics |
We conducted a systematic study of top susceptibility variants from a genome-wide association (GWA) study of bipolar disorder to gain insight into the functional consequences of genetic variation influencing disease risk. We report here the results of experiments to explore the effects of these susceptibility variants on DNA methylation and mRNA expression in human cerebellum samples. Among the top susceptibility variants, we identified an enrichment of cis regulatory loci on mRNA ...
Known for Bipolar Disorder | Gene Expression | Trait Loci | Methylation Quantitative | Susceptibility Variants |
Suggestive Evidence for a Schizophrenia Susceptibility Locus on Chromosome 6q and a Confirmation in an Independent Series of Pedigrees
[ PUBLICATION ]
We have investigated whether there is a locus on chromosome 6 that confers an increased susceptibility to schizophrenia using a two-stage approach and nonparametric linkage analysis. Allele sharing identical by descent (IBD) and multipoint maximum likelihood score (MLS) statistics were employed. Results from two tested data sets, a first data set, or genome scanning data set, and a second replication data set, show excess allele sharing for multiple markers in 6q, a chromosomal region ...
Known for Susceptibility Locus | Suggestive Evidence | Chromosome 6q | Human Pair | Excess Allele Sharing |
Key People For Bipolar Disorder
Elliot S Gershon:Expert Impact
Concepts for whichElliot S Gershonhas direct influence:Bipolar disorder, Psychotic disorders, Affective disorders, Affective disorder, Human pair, Affective illness, Attempted suicide, Genetic linkage.
Elliot S Gershon:KOL impact
Concepts related to the work of other authors for whichfor which Elliot S Gershon has influence:Bipolar disorder, Dna methylation, Major depression, Gene expression, Anorexia nervosa, Human pair, Mental health.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |